Association between plasma adiponectin levels and unstable coronary syndromes

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Syndrome

Background:

• Obesity is a known risk factor for acute coronary syndrome (ACS).
• The link between elevated body mass index (BMI) and ACS persists independently of traditional risk factors.
• This suggests other mediators related to body fat may contribute to ACS risk.

Purpose of the Study:

• To investigate the association between plasma adiponectin levels and the risk of acute coronary syndrome (ACS).

Main Methods:

• A cohort of 499 patients undergoing coronary angiography was analyzed.
• Patients were categorized into groups with and without ACS.
• Multiple regression analysis was employed to assess independent associations.

Main Results:

• Higher plasma adiponectin levels were independently associated with a significantly lower risk of ACS (OR = 0.61; P < 0.001).
• Conversely, higher BMI, prior myocardial infarction, C-reactive protein, and coronary artery disease severity were linked to increased ACS risk.
• The lowest risk of ACS was observed at adiponectin levels below or equal to 5.5 microg/mL.

Conclusions:

• Elevated plasma adiponectin levels demonstrate an independent inverse relationship with the risk of acute coronary syndrome (ACS).
• Adiponectin may serve as a potential biomarker for cardiovascular risk assessment in relation to obesity.